Pressure-independent effects of AT1-receptor antagonism on cardiovascular remodeling in aortic-banded rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 272, Issue 5 41-5, 1997, Pages

  Regan, Christopher P ^a   Anderson, Peter G ^a   Bishop, Sanford P ^a   Berecek, Kathleen H ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

angiotensin II; hypertension; left ventricular hypertrophy; losartan

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; LOSARTAN;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY MEDIA; ARTICLE; CONTROLLED STUDY; CORONARY VASCULAR RESISTANCE; FIBROSIS; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030924923     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.272.5.h2131     Document Type: Article

References (21)

1. Anderson, P. G., S. B. Digerness, J. L. Sklar, and P. J. Boor. Use of the isolated perfused heart for evaluation of cardiac toxicity. Toxicol. Pathol. 1990.
2. Arai, M., A. Yoguchi, T. Iso, T. Takahashi, S. Imai, K. Murata, and T. Suzuki. Endothelin-1 and its binding sites are upregulated in pressure overload cardiac hypertrophy. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H2084-H2091, 1995.
3. Brilla, C., L. Matsubara, and K. Weber. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J, Mol. Cell. Cardiol. 25: 563-575, 1993.
4. Brilla, C., R. Pick, L. Tan, J. Janicki, and K. Weber. Remodeling of the rat right and left ventricles in experimental hypertension. Circ. Res. 67: 1355-1364, 1990.
5. 1 receptor. Am. J. Hypertens. 5: 276-280, 1992.
6. Fornes, P., C. Richer, E. Vacher, P. Bruneval, and J. F. Giudicelli. Losartan's protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal. J. Cardiovasc. Pharmacol. 22: 305-313, 1993.
7. Fullerton, M. J., and J. W. Funder. Aldosterone and cardiac fibrosis: in vitro studies. Cardiovasc. Res. 28: 1863-1867, 1994.
8. Geisterfer, A., M. Peach, and G. Owens. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62: 749-756, 1988.
9. Gohlke, P., W. Linz, B. Scholkens, I. Kuiver, S. Bartenbach, A. Schnell, and T. Unger. Angiotensin converting enzyme inhibition improves cardiac function: role of bradykinin. Hypertension 23: 411-418, 1994.
10. Golomb, E., Z. Abassi, G. Cuda, M. Stylianou, V. Panchal, D. Trachewsky, and H. Keiser. Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H1496-H1506, 1994.
11. Gosse, P., J. Grellet, S. Bonoron, L. Tariosse, P. Besse, and M. Dallocchio. Effects of perindopril on left ventricular hypertrophy, coronary blood flow, and mechanical properties of cardiac muscle in renovascular hypertensive rats. Am. J. Hypertens. 4, Suppl. 3, pt. 2: 235S-239S, 1991.
12. Griffin, S., W. Brown, F. MacPherson, L. McGrath, V. Wilson, N. Korsgaard, M. Mulvany, and A. Lever. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 17: 626-635, 1991.
13. Kato, H., H. Suzuki, S. Tajima, Y. Ogata, T. Tominaga, A. Sato, and T. Saruta. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J. Hypertens. 9: 17-22, 1991.
14. Kojima, M., I. Shiojima, T. Yamazaki, I. Komuro, Z. Yunzeng, W. Ying, T. Mizuno, K. Ueki, K. Tobe, T. Kadowaki, R. Nagai, and Y. Yazaki. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation 89: 2204-2211, 1994.
15. Komuro, I., S. Kudo, T. Yamazaki, Y. Zou, I. Shiojima, and Y. Yazaki. Mechanical stretch activates the stress-activated protein kinases in cardiac myocytes. FASEB J. 10: 631-636, 1996.
16. Levy, D., R. Garrison, D. Savage, W. Kannel, and W. Castelli. Prognostic implications of echocardiograhically determined left ventricular mass in the framingham heart study. N. Engl. J. Med. 322: 1561-1566, 1990.
17. Linz, W., R. Henning, and B. Scholkens. Role of angiotensin converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats. J. Hypertens. 9, Suppl. 6: S400-S401, 1991.
18. 1 receptor. J. Hypertens. 10: 1463-1469, 1992.
19. 1 receptor an-tagonist, and surgical reversal. J. Cardiovasc. Pharmacol. 23: 291-299, 1994.
20. Nagano, M., J. Higaki, H. Mikami, M. Nakamuru, K. Higashimori, K. Katahina, Y. Tabuchi, A. Moriguchi, F. Nakamura, and T. Ogihara. Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats. J. Hypertens. 9: 595-599, 1991.
21. Nicoletti, A., D. Heudes, N. Hinglias, M. D. Appay, M. Philippe, C. Prigent, J. Bariety, and J. B. Michel. Left ventricular fibrosis in renovascular hypertensive rats. Hypertension 26: 101-111, 1995.